Abstract
BackgroundKnowledge of the prevalence of morbidity secondary to stroke is important for health care professionals, health care commissioners, third sector organizations, and stroke survivors to understand the likely progress of poststroke sequelae and to aid in commissioning decisions, planning care, and adjusting to life after stroke.ObjectiveThe primary aim of the Morbidity PRevalence Estimate In StrokE (MORe PREcISE) study is to determine the prevalence of morbidity secondary to a stroke, predictors of morbidity, and trends in quality of life and functional status using patient-reported outcomes, cognitive and functional assessments.MethodsA total of 500 participants will be recruited across Wales and England within 14 days following an admission to a stroke unit for either an ischemic or hemorrhagic stroke as part of a multicenter cohort study. Participants are assessed at baseline ≤14 days poststroke and subsequently at 90 (± 14) days and 180 (± 14) days poststroke. At each time point, data will be collected relating to the following domains: participant demographics, routine clinical, patient reported, cognitive status, emotional well-being, and functional ability.ResultsRecruitment commenced in October 2018 with 20 sites opened as of September 2019 and was closed on October 31, 2019.ConclusionsThe primary outcome is the prevalence of morbidity at 6 months secondary to a stroke. Further analysis will consider temporal changes in the health-related domains to describe trends among baseline, 3-, and 6-month time points.Trial RegistrationClinicalTrials.gov NCT03605381; https://clinicaltrials.gov/ct2/show/NCT03605381International Registered Report Identifier (IRRID)DERR1-10.2196/15851
Highlights
Stroke MorbidityThere are 1.2 million stroke survivors currently living in the United Kingdom [1]
This paper describes the protocol for the Morbidity Prevalence Estimate at 6 Months Following a Stroke (MORe PREcISE) study (ClinicalTrials.gov NCT03605381—Registered: 30/07/19)
The primary objective is to determine the prevalence of morbidity at 6 months secondary to a stroke, predictors of morbidity, trends in health-related quality of life (HRQoL), and function
Summary
There are 1.2 million stroke survivors currently living in the United Kingdom [1]. mortality as a consequence of stroke is decreasing [1,2], over two-thirds of stroke survivors have a form of disability on discharge from hospital [3]. The prevalence of morbidity secondary to stroke is of central importance to health professionals to understand the prognosis of the disease in patients under their care. The ICHOM Standard Set for Stroke takes important steps to collect data outside of the process of care data in areas such as patient-reported outcome data, which includes domains such as toileting, walking, and assistance with feeding. The ICHOM group does not advocate the specific collection of data related to cognitive impairment or emotional problems secondary to stroke. The scope of this study is to build on routinely collected health care and poststroke data not currently collected by the ICHOM Standard Set for Stroke for the purpose of estimating morbidity prevalence
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
